menu
    • menu

    Company profile for MitoRx Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MitoRx Therapeutics is a biopharmaceutical company with a first-in-class and first-in-target platform designed to potentially halt the progression of challenging diseases. Headquartered in Oxford and Exeter, UK, the company is initially concentrating on three rare indications while seeking partnerships for broader applications. MitoRx is advancing a pipeline of pre-clinical programs with its MTRX technology, which has demonstr...
    MitoRx Therapeutics is a biopharmaceutical company with a first-in-class and first-in-target platform designed to potentially halt the progression of challenging diseases. Headquartered in Oxford and Exeter, UK, the company is initially concentrating on three rare indications while seeking partnerships for broader applications. MitoRx is advancing a pipeline of pre-clinical programs with its MTRX technology, which has demonstrated pharmacological utility in various in vivo models over more than a decade of research, as evidenced by over twenty publications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MitoRx Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Harwell, Oxford
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mitorxtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/mitorx-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MitoRxTheraLtd?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MitoRx Appoints Chief Scientific Officer
    MitoRx Appoints Chief Scientific Officer

    01 May 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/mitorx-appoints-chief-scientific-officer/

    CONTRACTPHARMA
    01 May 2025
    Share Share
    MitoRx Appoints Chief Business Officer And Finance Director
    MitoRx Appoints Chief Business Officer And Finance Director

    09 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/09/3006836/0/en/MitoRx-Therapeutics-Expands-Leadership-Team-with-Strategic-Appointments-of-Chief-Business-Officer-and-Finance-Director.html

    GLOBENEWSWIRE
    09 Jan 2025
    Share Share
    MitoRx Therapeutics AP39 Alleviates Obesity In Published Study
    MitoRx Therapeutics AP39 Alleviates Obesity In Published Study

    10 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/10/2961023/0/en/MitoRx-Therapeutics-Announces-Publication-Showing-Mitochondrial-Sulfide-Donor-AP39-Significantly-Alleviates-Obesity.html

    GLOBENEWSWIRE
    10 Oct 2024
    Share Share
    MitoRx Adds Leaders, Reveals New Obesity Program
    MitoRx Adds Leaders, Reveals New Obesity Program

    03 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/03/2957451/0/en/MitoRx-Therapeutics-Strengthens-Leadership-with-Key-Appointments-as-it-Reveals-Obesity-Programme.html

    GLOBENEWSWIRE
    03 Oct 2024
    Share Share
    MitoRx Therapeutics Strengthens Scientific Advisory Board
    MitoRx Therapeutics Strengthens Scientific Advisory Board

    07 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/07/2841980/0/en/MitoRx-Therapeutics-Strengthens-Scientific-Advisory-Board-with-Appointment-of-Four-International-Experts.html

    GLOBENEWSWIRE
    07 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search